Reputation

In Surprising Twist, Trust Rises for Healthcare Companies

In Surprising Twist, Trust Rises for Healthcare Companies

But will pharma and biotechnology firms be able to advance this year's positive momentum?

Pharma Execs Can Do More to Address Industry's Reputation

Pharma Execs Can Do More to Address Industry's Reputation

Some leaders have stepped up, and this serves their companies - and the industry - well.

Is the Trump Administration the Cure the FDA Needs?

Is the Trump Administration the Cure the FDA Needs?

Finally, a Congress and president who see pharma as a resource and not a villain, Flaum writes.

Drugmakers: Take a Note From P&G, and Generate Some Goodwill

Drugmakers: Take a Note From P&G, and Generate Some Goodwill

We, as an industry, frighten rather than inform, cover our butts rather than support, and confuse rather than encourage.

Americans are increasingly critical of drug industry, a new poll finds

Americans are increasingly critical of drug industry, a new poll finds

By

A tracking poll conducted by the Kaiser Family Foundation also found that fewer Americans are seeing prescription drug ads compared to last year.

Pfizer ad celebrates the sweat and science behind the little blue pills

Pfizer ad celebrates the sweat and science behind the little blue pills

By

As Viagra goes generic, the pharma giant launches a feel-good corporate campaign.

Five things for pharma marketers to know: Friday, May 27, 2016

Five things for pharma marketers to know: Friday, May 27, 2016

By By

Baby powder lawsuit impacts J&J's reputation; new bacterial infection raises concern about treatment options; Valeant reportedly rejected offer from Takeda

Zika Crisis Stresses Need for Pharma Industry

Zika Crisis Stresses Need for Pharma Industry

By

When pharmaceutical companies are needed, we're Jonas Salks; when we ask to be paid, we're Martin Shkrelis.

Five things for pharma marketers to know: Wednesday, September 30, 2015

Five things for pharma marketers to know: Wednesday, September 30, 2015

By

Teva exec says pharma needs to pay attention to its reputation; academics who serve on boards of healthcare companies face potential conflicts of interest; WHO recommendation will boost number of people taking anti-retrovirals

Will Pharma Have an Ashley Madison Moment?

Will Pharma Have an Ashley Madison Moment?

Ashley Madison's lesson must be heeded. For all the good pharma has done for the world, it has also created its share of ethical quagmires.

Pfizer's "Get Old" campaign gets youthful

Pfizer's "Get Old" campaign gets youthful

By

The three-year-old campaign's youthful tone evolves as its audience ages.

In their words: the most inspirational speakers at the 2014 Lions Health

By

An MM&M roundup of what the festival's most inspirational speakers had to say about creativity in healthcare and challenges like talent recruitment and implementing digital innovation.

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.